NEW YORK, July 31, 2026 /PRNewswire/ -- 
    
                
                    
                
    
Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers

<p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">NEW YORK</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">July 31, 2026</span> /PRNewswire/ -- </p>
    <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
                <p xmlns="http://www.w3.org/1999/xhtml">
                    <img xmlns="http://www.w3.org/1999/xhtml" src="https://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA2820508" title="Rosen Law Firm Logo" alt="Rosen Law Firm Logo"></img>
                </p>
    </div>
<p xmlns="http://www.w3.org/1999/xhtml">Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/PHH">PHH</a>, BYAH)) between December 27, 2024 and July 8, 2025, inclusive (the &#34;Class Period&#34;). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2026.</p><p xmlns="http://www.w3.org/1999/xhtml">So what: If you purchased Park Ha securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.</p><p xmlns="http://www.w3.org/1999/xhtml">What to do next: To join the Park Ha class action, go to <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=4141386148&amp;u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin&amp;a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin" target="_blank" rel="nofollow">https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join</a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:case@rosenlegal.com" target="_blank" rel="nofollow">case@rosenlegal.com</a> for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.</p><p xmlns="http://www.w3.org/1999/xhtml">Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs&#39; Bar. Many of the firm&#39;s attorneys have been recognized by Lawdragon and Super Lawyers.</p><p xmlns="http://www.w3.org/1999/xhtml">Details of the case: According to the lawsuit, throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Park Ha Biological Technology Co. Ltd.&#39;s business, operations, and the true nature of its securities trading activity. Specifically, defendants failed to disclose that: (1) Park Ha was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) Park Ha&#39;s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; (3) Park Ha&#39;s IPO was intentionally structured with an extremely low public float to enable the manipulation scheme; and (4) as a result of the foregoing, defendants&#39; positive statements about Park Ha&#39;s business, operations, and prospects were misleading and/or lacked a reasonable basis.</p><p xmlns="http://www.w3.org/1999/xhtml">To join the Park Ha class action, go to <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=4141386148&amp;u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin&amp;a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin" target="_blank" rel="nofollow">https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join</a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:case@rosenlegal.com" target="_blank" rel="nofollow">case@rosenlegal.com</a> for information on the class action.</p><p xmlns="http://www.w3.org/1999/xhtml">No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor&#39;s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p><p xmlns="http://www.w3.org/1999/xhtml">Follow us for updates on LinkedIn: <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=3055989778&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&amp;a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm" target="_blank" rel="nofollow">https://www.linkedin.com/company/the-rosen-law-firm</a>, on Twitter: <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=2353200710&amp;u=https%3A%2F%2Ftwitter.com%2Frosen_firm&amp;a=https%3A%2F%2Ftwitter.com%2Frosen_firm" target="_blank" rel="nofollow">https://twitter.com/rosen_firm</a> or on Facebook: <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=2088761195&amp;u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&amp;a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F" target="_blank" rel="nofollow">https://www.facebook.com/rosenlawfirm/</a>.</p><p xmlns="http://www.w3.org/1999/xhtml">Attorney Advertising. Prior results do not guarantee a similar outcome.</p><p xmlns="http://www.w3.org/1999/xhtml">Contact Information:</p><p xmlns="http://www.w3.org/1999/xhtml" class="prnml40">Laurence Rosen, Esq.<br xmlns="http://www.w3.org/1999/xhtml"></br>Phillip Kim, Esq.<br xmlns="http://www.w3.org/1999/xhtml"></br>The Rosen Law Firm, P.A.<br xmlns="http://www.w3.org/1999/xhtml"></br>275 Madison Avenue, 40th Floor<br xmlns="http://www.w3.org/1999/xhtml"></br>New York, NY 10016<br xmlns="http://www.w3.org/1999/xhtml"></br>Tel: (212) 686-1060<br xmlns="http://www.w3.org/1999/xhtml"></br>Toll Free: (866) 767-3653<br xmlns="http://www.w3.org/1999/xhtml"></br>Fax: (212) 202-3827<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" href="mailto:case@rosenlegal.com" target="_blank" rel="nofollow">case@rosenlegal.com</a><br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=3785791882&amp;u=http%3A%2F%2Fwww.rosenlegal.com%2F&amp;a=www.rosenlegal.com" target="_blank" rel="nofollow">www.rosenlegal.com</a></p>



<p xmlns="http://www.w3.org/1999/xhtml" id="PURL"><img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=DC17193&amp;sd=2026-07-31"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302840422.html" target="_blank">https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302840422.html</a></p><p xmlns="http://www.w3.org/1999/xhtml">SOURCE THE ROSEN LAW FIRM, P. A.</p>

BYAH

PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit

Park Ha Biological BYAH Faces Securities Class Action With Limited Details

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>NEW YORK, July 31, 2026 /PRNewswire/ -- 
    
                
                    
                
    
Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Rosen Law Firm announced a securities class action against Park Ha Biological Technology Co., Ltd. (PHH, BYAH) covering December 27, 2024 through July 8, 2025. The suit alleges misleading statements and undisclosed promotional activity, including low float enabling manipulation. Lead plaintiff filings are due by September 28, 2026, and no class has been certified yet, leaving near-term fundamental impact uncertain.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Rosen Law Firm files a securities class action against Park Ha BYAH/PHH.</li><li>Class Period spans December 27, 2024 to July 8, 2025.</li><li>Lead plaintiff deadline is September 28, 2026; no class certified yet.</li><li>Allegations include stock promotion, false statements, and extremely low float.</li><li>No immediate payout or settlement details; impact depends on facts and certification.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Park Ha Biological Technology Co., Ltd. (PHH/BYAH)</strong>: Subject of securities class action; potential near-term price volatility.</li><li><strong>Rosen Law Firm, P.A. (N/A)</strong>: Filing firm; high-profile investor rights firm with historical settlements.</li><li><strong>Phillip Kim, Esq. (N/A)</strong>: Lead contact for the class action inquiry; no direct market impact implied.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Category: Legal. This is a securities class-action notice tied to Park Ha BYAH/PHH; the stock impact hinges on certification and substantive case facts rather than the filing alone.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>BYAH could show short-term volatility on litigation headlines.</li><li>No class certification yet; potential payout remains uncertain.</li><li>Lead-plaintiff deadline is September 28, 2026.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Park Ha Biological Technology Co., Ltd. (PHH/BYAH).</li><li>Class Period: December 27, 2024 – July 8, 2025.</li><li>Lead Plaintiff deadline: September 28, 2026.</li><li>No Class Certified yet.</li><li>Rosen Law Firm leading the action.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Neutral to modestly bearish near term; monitor volatility ahead of the Sep 28, 2026 lead plaintiff deadline.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml"><span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">NEW YORK</span>, <span xmlns="http://www.w3.org/1999/xhtml" class="legendSpanClass">July 31, 2026</span> /PRNewswire/ -- </p>
    <div xmlns="http://www.w3.org/1999/xhtml" class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1">
                <p xmlns="http://www.w3.org/1999/xhtml">
                    <img xmlns="http://www.w3.org/1999/xhtml" src="https://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA2820508" title="Rosen Law Firm Logo" alt="Rosen Law Firm Logo"></img>
                </p>
    </div>
<p xmlns="http://www.w3.org/1999/xhtml">Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/quote/PHH">PHH</a>, BYAH)) between December 27, 2024 and July 8, 2025, inclusive (the &#34;Class Period&#34;). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2026.</p><p xmlns="http://www.w3.org/1999/xhtml">So what: If you purchased Park Ha securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.</p><p xmlns="http://www.w3.org/1999/xhtml">What to do next: To join the Park Ha class action, go to <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=4141386148&amp;u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin&amp;a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin" target="_blank" rel="nofollow">https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join</a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:case@rosenlegal.com" target="_blank" rel="nofollow">case@rosenlegal.com</a> for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.</p><p xmlns="http://www.w3.org/1999/xhtml">Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs&#39; Bar. Many of the firm&#39;s attorneys have been recognized by Lawdragon and Super Lawyers.</p><p xmlns="http://www.w3.org/1999/xhtml">Details of the case: According to the lawsuit, throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Park Ha Biological Technology Co. Ltd.&#39;s business, operations, and the true nature of its securities trading activity. Specifically, defendants failed to disclose that: (1) Park Ha was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) Park Ha&#39;s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; (3) Park Ha&#39;s IPO was intentionally structured with an extremely low public float to enable the manipulation scheme; and (4) as a result of the foregoing, defendants&#39; positive statements about Park Ha&#39;s business, operations, and prospects were misleading and/or lacked a reasonable basis.</p><p xmlns="http://www.w3.org/1999/xhtml">To join the Park Ha class action, go to <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=4141386148&amp;u=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin&amp;a=https%3A%2F%2Frosenlegal.com%2Fcases%2Fpark-ha-biological-technology-co-ltd-2026%2Fjoin" target="_blank" rel="nofollow">https://rosenlegal.com/cases/park-ha-biological-technology-co-ltd-2026/join</a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:case@rosenlegal.com" target="_blank" rel="nofollow">case@rosenlegal.com</a> for information on the class action.</p><p xmlns="http://www.w3.org/1999/xhtml">No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor&#39;s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.</p><p xmlns="http://www.w3.org/1999/xhtml">Follow us for updates on LinkedIn: <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=3055989778&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm&amp;a=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fthe-rosen-law-firm" target="_blank" rel="nofollow">https://www.linkedin.com/company/the-rosen-law-firm</a>, on Twitter: <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=2353200710&amp;u=https%3A%2F%2Ftwitter.com%2Frosen_firm&amp;a=https%3A%2F%2Ftwitter.com%2Frosen_firm" target="_blank" rel="nofollow">https://twitter.com/rosen_firm</a> or on Facebook: <a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=2088761195&amp;u=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F&amp;a=https%3A%2F%2Fwww.facebook.com%2Frosenlawfirm%2F" target="_blank" rel="nofollow">https://www.facebook.com/rosenlawfirm/</a>.</p><p xmlns="http://www.w3.org/1999/xhtml">Attorney Advertising. Prior results do not guarantee a similar outcome.</p><p xmlns="http://www.w3.org/1999/xhtml">Contact Information:</p><p xmlns="http://www.w3.org/1999/xhtml" class="prnml40">Laurence Rosen, Esq.<br xmlns="http://www.w3.org/1999/xhtml"></br>Phillip Kim, Esq.<br xmlns="http://www.w3.org/1999/xhtml"></br>The Rosen Law Firm, P.A.<br xmlns="http://www.w3.org/1999/xhtml"></br>275 Madison Avenue, 40th Floor<br xmlns="http://www.w3.org/1999/xhtml"></br>New York, NY 10016<br xmlns="http://www.w3.org/1999/xhtml"></br>Tel: (212) 686-1060<br xmlns="http://www.w3.org/1999/xhtml"></br>Toll Free: (866) 767-3653<br xmlns="http://www.w3.org/1999/xhtml"></br>Fax: (212) 202-3827<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" href="mailto:case@rosenlegal.com" target="_blank" rel="nofollow">case@rosenlegal.com</a><br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4743784-1&amp;h=3785791882&amp;u=http%3A%2F%2Fwww.rosenlegal.com%2F&amp;a=www.rosenlegal.com" target="_blank" rel="nofollow">www.rosenlegal.com</a></p>



<p xmlns="http://www.w3.org/1999/xhtml" id="PURL"><img xmlns="http://www.w3.org/1999/xhtml" title="Cision" width="12" height="12" alt="Cision" src="https://edge.prnewswire.com/c/img/favicon.png?sn=DC17193&amp;sd=2026-07-31"></img> View original content to download multimedia:<a xmlns="http://www.w3.org/1999/xhtml" id="PRNURL" rel="nofollow" href="https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302840422.html" target="_blank">https://www.prnewswire.com/news-releases/phh-byah-investors-have-opportunity-to-lead-park-ha-biological-technology-co-ltd-securities-lawsuit-302840422.html</a></p><p xmlns="http://www.w3.org/1999/xhtml">SOURCE THE ROSEN LAW FIRM, P. A.</p>

Rosen Law Firm announced a securities class action against Park Ha Biological Technology Co., Ltd. (PHH, BYAH) covering December 27, 2024 through July 8, 2025. The suit alleges misleading statements and undisclosed promotional activity, including low float enabling manipulation. Lead plaintiff filings are due by September 28, 2026, and no class has been certified yet, leaving near-term fundamental impact uncertain.

News insight

PHH, BYAH Investors Have Opportunity to Lead Park Ha Biological Technology Co., Ltd. Securities Lawsuit

AI summary

Sentiment rationale

Key facts

Legal